A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...
Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...
For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...
The shift could cut off tens of thousands of people from treatment.
A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...
Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...
Harerimana Ismail of Uganda is a community health worker who checks on kids with HIV. He lost his salary after the Trump ...
What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best option for them?
A public health emergency is about to emerge because of federal ADAP (AIDS Drug Assistance Program) funding cuts. Long since retired, but a public health educator to the end, I’d like to remind ...
Thousands of low-income Americans with HIV are losing access to vital medications, as states grapple with a lack of federal ...
The HIV prevention shot lenacapavir will be rolled out at South African clinics within the next couple of months — from 2027, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results